Effects of CCK-tetrapeptide in patients
✍
Martin A. Katzman; Diana Koszycki; Jacques Bradwejn
📂
Article
📅
2004
🏛
John Wiley and Sons
🌐
English
⚖ 105 KB
👁 1 views
Panicogenic sensitivity to CCK-tetrapeptide (CCK-4) is enhanced in panic disorder patients relative to normal controls (NC). We sought to determine whether CCK-4 sensitivity is augmented in patients with social phobia (SP) (n ¼ 12) and obsessive-compulsive disorder (OCD) (n ¼ 8) versus NC (n ¼ 12).